======= RNF20 =======
== Gene Information ==
* **Official Symbol**: RNF20
* **Official Name**: ring finger protein 20
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56254|56254]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q5VTR2|Q5VTR2]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=RNF20&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RNF20|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/607699|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The protein encoded by this gene shares similarity with BRE1 of S. cerevisiae. The protein encoded by this human gene is an E3 ubiquitin ligase that regulates chromosome structure by monoubiquitinating histone H2B. This protein acts as a putative tumor suppressor and positively regulates the p53 tumor suppressor as well as numerous histone H2A and H2B genes. In contrast, this protein also suppresses the expression of several protooncogenes and growth-related genes, including many genes that are induced by epidermal growth factor. This gene selectively suppresses the expression of some genes by interfering with chromatin recruitment of transcription elongation factor SII (TFIIS). [provided by RefSeq, Feb 2012].
* **UniProt Summary**: N/A
No Pfam Domain information is available for this gene.
|positive regulation of histone H2B ubiquitination|
|regulation of histone H2B ubiquitination|
|positive regulation of histone ubiquitination|
|HULC complex|
|negative regulation of mRNA polyadenylation|
|negative regulation of mRNA 3-end processing|
|histone H2B ubiquitination|
|regulation of histone ubiquitination|
|regulation of mRNA polyadenylation|
|negative regulation of mRNA processing|
|regulation of mRNA 3-end processing|
|histone monoubiquitination|
|positive regulation of histone methylation|
|histone ubiquitination|
|protein monoubiquitination|
|regulation of histone methylation|
|p53 binding|
|mRNA 3-UTR binding|
|negative regulation of mRNA metabolic process|
|positive regulation of histone modification|
|positive regulation of chromatin organization|
|ubiquitin ligase complex|
|positive regulation of protein ubiquitination|
|histone binding|
|positive regulation of protein modification by small protein conjugation or removal|
|regulation of mRNA processing|
|regulation of histone modification|
|positive regulation of chromosome organization|
|regulation of chromatin organization|
|regulation of protein ubiquitination|
|regulation of protein modification by small protein conjugation or removal|
|ubiquitin-protein transferase activity|
|negative regulation of cell migration|
|negative regulation of cell motility|
|transcription coactivator activity|
|ubiquitin protein ligase binding|
|protein polyubiquitination|
|negative regulation of cellular component movement|
|negative regulation of locomotion|
|regulation of mRNA metabolic process|
|regulation of chromosome organization|
|histone modification|
|covalent chromatin modification|
|chromatin binding|
|ubiquitin-dependent protein catabolic process|
|modification-dependent protein catabolic process|
|modification-dependent macromolecule catabolic process|
|proteolysis involved in cellular protein catabolic process|
|cellular protein catabolic process|
|positive regulation of organelle organization|
|regulation of mitotic cell cycle|
|protein catabolic process|
|protein ubiquitination|
|chromatin organization|
|protein modification by small protein conjugation|
|regulation of cell migration|
|nucleolus|
|cellular macromolecule catabolic process|
|regulation of cell motility|
|regulation of locomotion|
|protein modification by small protein conjugation or removal|
|regulation of cellular component movement|
|macromolecule catabolic process|
|organonitrogen compound catabolic process|
|chromosome organization|
|regulation of cell cycle|
|positive regulation of cellular component organization|
|positive regulation of protein modification process|
|proteolysis|
|regulation of organelle organization|
|negative regulation of RNA metabolic process|
|negative regulation of nucleobase-containing compound metabolic process|
|positive regulation of transcription, DNA-templated|
|positive regulation of cellular protein metabolic process|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|positive regulation of protein metabolic process|
|negative regulation of gene expression|
|positive regulation of RNA metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
|regulation of protein modification process|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp135|MS023 7μM R03 exp135]]|-2.25|
|[[:results:exp461|BS-181 20μM R08 exp461]]|-2.03|
|[[:results:exp470|Chloroquine 32μM R08 exp470]]|-2.02|
^Gene^Correlation^
|[[:human genes:r:rrm1|RRM1]]|0.509|
|[[:human genes:r:rnf40|RNF40]]|0.43|
Global Fraction of Cell Lines Where Essential: 22/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|2/28|
|blood|2/28|
|bone|2/25|
|breast|3/33|
|central nervous system|1/56|
|cervix|0/4|
|colorectal|1/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|1/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|1/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|1/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|1/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 1490
* **Expression level (log2 read counts)**: 6.01
{{:chemogenomics:nalm6 dist.png?nolink |}}